# Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve Replacement System With Retrievable Delivery Catheter System

> **NCT04744857** · NA · COMPLETED · sponsor: **Peijia Medical Technology (Suzhou) Co., Ltd.** · enrollment: 85 (actual)

## Conditions studied

- Aortic Stenosis

## Interventions

- **COMBINATION_PRODUCT:** The experimental apparatus consisted of artificial aortic valve, transporter and grip-loading system.

## Key facts

- **NCT ID:** NCT04744857
- **Lead sponsor:** Peijia Medical Technology (Suzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-13
- **Primary completion:** 2020-10-16
- **Final completion:** 2020-10-16
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2021-02-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04744857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04744857, "Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve Replacement System With Retrievable Delivery Catheter System". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04744857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*